These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

375 related articles for article (PubMed ID: 17276749)

  • 1. Early pharmacological treatment of autism: a rationale for developmental treatment.
    Bethea TC; Sikich L
    Biol Psychiatry; 2007 Feb; 61(4):521-37. PubMed ID: 17276749
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Review of the evidence for treatment of children with autism with selective serotonin reuptake inhibitors.
    West L; Brunssen SH; Waldrop J
    J Spec Pediatr Nurs; 2009 Jul; 14(3):183-91. PubMed ID: 19614827
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Treating functional impairment of autism with selective serotonin-reuptake inhibitors.
    Moore ML; Eichner SF; Jones JR
    Ann Pharmacother; 2004 Sep; 38(9):1515-9. PubMed ID: 15292500
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Selective serotonin reuptake inhibitors in autism: a review of efficacy and tolerability.
    Kolevzon A; Mathewson KA; Hollander E
    J Clin Psychiatry; 2006 Mar; 67(3):407-14. PubMed ID: 16649827
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The use of selective serotonin reuptake inhibitors in autism and related disorders.
    Posey DJ; Erickson CA; Stigler KA; McDougle CJ
    J Child Adolesc Psychopharmacol; 2006; 16(1-2):181-6. PubMed ID: 16553538
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Medication treatment in subjects with autistic spectrum disorders.
    Buitelaar JK; Willemsen-Swinkels SH
    Eur Child Adolesc Psychiatry; 2000; 9 Suppl 1():I85-97. PubMed ID: 11140783
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Psychopharmacologic interventions for repetitive behaviors in autism spectrum disorders.
    Soorya L; Kiarashi J; Hollander E
    Child Adolesc Psychiatr Clin N Am; 2008 Oct; 17(4):753-71, viii. PubMed ID: 18775368
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmacologic treatment of autism.
    Palermo MT; Curatolo P
    J Child Neurol; 2004 Mar; 19(3):155-64. PubMed ID: 15119475
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Review of psychopharmacological treatments in adolescents and adults with autistic disorders].
    Baghdadli A; Gonnier V; Aussilloux C
    Encephale; 2002; 28(3 Pt 1):248-54. PubMed ID: 12091786
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Children and autism--Part 1--recognition and pharmacological management.
    Angley M; Young R; Ellis D; Chan W; McKinnon R
    Aust Fam Physician; 2007 Sep; 36(9):741-4. PubMed ID: 17915375
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacotherapeutic management of autism.
    Posey DJ; McDougle CJ
    Expert Opin Pharmacother; 2001 Apr; 2(4):587-600. PubMed ID: 11336609
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The developmental disruptions of serotonin signaling may involved in autism during early brain development.
    Yang CJ; Tan HP; Du YJ
    Neuroscience; 2014 May; 267():1-10. PubMed ID: 24583042
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Stereotypy II: a review of neurobiological interpretations and suggestions for an integration with behavioral methods.
    Rapp JT; Vollmer TR
    Res Dev Disabil; 2005; 26(6):548-64. PubMed ID: 16303583
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Selective serotonin reuptake inhibitors (SSRIs) for autism spectrum disorders (ASD).
    Williams K; Wheeler DM; Silove N; Hazell P
    Cochrane Database Syst Rev; 2010 Aug; (8):CD004677. PubMed ID: 20687077
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Vitamin D, neurosteroids and autism.
    Máčová L; Bičíková M; Ostatníková D; Hill M; Stárka L
    Physiol Res; 2017 Sep; 66(Suppl 3):S333-S340. PubMed ID: 28948817
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Fluorine magnetic resonance spectroscopy measurement of brain fluvoxamine and fluoxetine in pediatric patients treated for pervasive developmental disorders.
    Strauss WL; Unis AS; Cowan C; Dawson G; Dager SR
    Am J Psychiatry; 2002 May; 159(5):755-60. PubMed ID: 11986128
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The status of pharmacotherapy for autism spectrum disorders.
    Myers SM
    Expert Opin Pharmacother; 2007 Aug; 8(11):1579-603. PubMed ID: 17685878
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Autism.
    Longhurst JG; Potenza MN; McDougle CJ
    N Engl J Med; 1997 Nov; 337(21):1555-6; author reply 1556-7. PubMed ID: 9380125
    [No Abstract]   [Full Text] [Related]  

  • 19. The effects of maternal antidepressant use on offspring behaviour and brain development: Implications for risk of neurodevelopmental disorders.
    Millard SJ; Weston-Green K; Newell KA
    Neurosci Biobehav Rev; 2017 Sep; 80():743-765. PubMed ID: 28629713
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lack of efficacy of citalopram in children with autism spectrum disorders and high levels of repetitive behavior: citalopram ineffective in children with autism.
    King BH; Hollander E; Sikich L; McCracken JT; Scahill L; Bregman JD; Donnelly CL; Anagnostou E; Dukes K; Sullivan L; Hirtz D; Wagner A; Ritz L;
    Arch Gen Psychiatry; 2009 Jun; 66(6):583-90. PubMed ID: 19487623
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.